- ¥1bn
- ¥616m
- ¥2bn
- 33
- 42
- 12
- 15
Annual balance sheet for PhoenixBio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,775 | 1,328 | 1,326 | 1,555 | 1,385 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 214 | 160 | 226 | 287 | 217 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,257 | 1,799 | 1,854 | 2,292 | 2,132 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 508 | 702 | 410 | 539 | 543 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,784 | 2,516 | 2,280 | 3,019 | 2,715 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 535 | 399 | 439 | 1,286 | 421 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,622 | 1,422 | 1,452 | 1,504 | 918 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,162 | 1,094 | 828 | 1,514 | 1,798 |
Total Liabilities & Shareholders' Equity | 2,784 | 2,516 | 2,280 | 3,019 | 2,715 |
Total Common Shares Outstanding |